By Matt Grossman

 

Boston Scientific Corp. on Wednesday adjusted its full-year earnings guidance by narrowing the forecast range compared with previous guidance.

For the full year, the medical-devices company said it now expects sales growth of 19% to 20% compared with last year, and adjusted earnings of $1.60 a share to $1.62 a share. In July, Boston Scientific had forecast adjusted earnings of $1.58 a share to $1.62 a share for the full year.

In the fourth quarter, Boston Scientific anticipates year-over year sales growth of 13% to 17% and adjusted earnings of 43 cents to 45 cents a share.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

October 27, 2021 06:59 ET (10:59 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Boston Scientific Charts.